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The in vivo immune response is subject to many modifying factors, both cellular 
and humoral (1-8). Modifiers of immunity  may act either as enhancers or suppressors. 
One of the most widely studied examples of cellular immunological enhancement is 
the cooperative effect  demonstrated between thymus- and marrow-derived cells for 
humoral antibody production (l, 2).  Cell synergism for amplification of graft-versus- 
host reaction has also been reported (3). In contrast, suppression of humoral antibody 
responses has been obtained using thymus-derived cells (4). I-Iumoral factors such as 
antibody (see reference 5 for review) and other diffusable  cell products can also exert 
suppresive (6) or augmenting (7-10) influences  on immunity. 
Affinity column chromatography of immunocompetent cells has been achieved by 
attaching  antigenic molecules  to  glass,  plastic,  polyacrylamide, or  agarose  beads 
(11-13) or to nylon threads (14). It was demonstrated that cells expressing antibody- 
like receptors on their surfaces were retained by the columns, whereas cells not possess- 
ing the relevant recognition receptors passed through the columns. 
Recent  studies  have  indicated  that  histamine,  beta  catecholamines,  and  pro- 
staglandins E~ and E2 can inhibit both the cytotoxic effects of lymphocytes sensitized 
to fibroblasts or mast cells (15) and the IgE-mediated release of histamine from human 
leukocytes (16).  Furthermore, receptors  for  histamine have been demonstrated on 
human peripheral blood leukocytes and mouse spleen cells  (17). Histamine has been 
insolubilized by chemical linkage via a protein carrier to agarose (Sepharose)  beads 
(17-18). Cells with preformed histamine receptors on their surfaces were specifically 
bound to the histamine-protein-Sepharose beads. 
Since the  technical aspects  of cell chromatography and the  attachment of 
histamine to  Sepharose  beads  are  known,  and  previous  studies  imply  that 
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histamine may serve as a modifier of immune  processes (15, 16), it was of interest 
to determine whether spleen cells passed over histamine-rabbit serum albumin- 
Sepharose  (H-RSA-S)  columns would  exhibit an  immune response potential 
different  from  that  of  unpassed  cells  or  of  cells  passed  over  rabbit  serum 
albumin-Sepharose (RSA-S) control columns. 
Materials  and  Methods 
Preparation  of H-RSA-S  and  RSA-S  Beads.--Histamine  was conjugated to rabbit serum 
albumin (RSA) by incubating  a solution of histamine with 1-ethyl-3-(3 dimethylaminopropyl) 
carbodimide (17). The resulting histamine-rabbit serum albumin conjugate (H-RSA) or RSA 
alone was attached to Sepharose 4 B (Pharmacia, Uppsala, Sweden) activated by CNBr. 
Preparation  of Cell Suspensions  ancl Filtration  over H-RSA-S and RSA-S Columns.--Spleen 
cell suspensions  were prepared in Eagle's medium (Microbiological  Associates, Inc., Jerusalem, 
Israel) as described elsewhere (19). The concentrations were estimated  by repeated sample 
counting using a hemacytometer. 
Aliquots of the cells (2.5 X  l0  T) to be filtered over the H-RSA-S or RSA-S columns were 
incubated at 37°C for 15 min with 0.6 ml of a 250/0 suspension of either H-RSA-S or RSA-S in 
Eagle's medium. The cell-bead mixtures were then poured into columns (made from plastic 
pipettes and containing a small piece of sponge in the bottom so as to retain the Sepharose but 
to permit passage of unbound cells), and the unattached cells were collected after the column 
had been washed twice with 1 ml of Eagle's medium. The cells that passed through the column 
were then recounted and adjusted to the concentration desired for injection. 
Cell Transfers  and  PFC Assays.--(BALB/c  X  C57BL/6)F1 female mice, 9-12 wk of age, 
were used as donors and recipients. Recipients were exposed to 750 rads of 6°Co  gamma irradia- 
tion and injected via the tail vein with 5 X 106 spleen cells mixed with 3 X 108 sheep erythro- 
cytes (SRBC) per recipient in a total volume of 1.0 ml. The recipient spleens were removed 
either 7 or 13 days after transfer and their contents were individually assayed for direct and 
indirect plaque-forming cells (PFC), respectively, using a modification of the hemolytic PFC 
assay (19) in agarose. 
RESULTS 
In order to determine whether passage of spleen cells over histamine-coated 
columns altered the immunocompetent properties of the cells not retained by 
the columns, and if so whether such an alteration could be attributed to cells 
bearing histamine receptors on their surfaces,  comparisons were made of  the 
direct  PFC  responses  generated  by  the  following cell  transfers  mixed  with 
3  X  10  s SRBC: (a) 5  >  106 spleen cells not passed over columns; (b) 5  X  106 
spleen cells passed over RSA-S control columns; and (c)  5  X  106 spleen cells 
passed  over H-RSA-S columns. The  spleen cell suspensions used in the first 
experiments  were  prepared  from  donors  which  had  been  immunized with 
3  X  l0  s SRBC  1 wk earlier, since the hemolytic plaque-forming cells of mice 
inmmnized with SRBC were shown to express receptors for histamine (18). The 
results of  the  direct PFC  responses,  assayed 7  days after transfer  (Table I), 
indicate  that  the  immunocompetence of  spleen  cells  passed  over  H-RSA-S 
columns was enhanced from 2.2- to 5.5-fold when compared with the response 
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when compared  with  responses  generated  by cells passed  over RSA-S  control 
columns. Recipient spleens of the H-RSA-S and unfractionated groups were also 
assayed 13 days after cell transfer for indirect PFC responses. Inocula of 5 X  106 
unfractionated cells  generated 23,100  4-  4950  and 3950  9=  580 indirect  PFC, 
TABLE I 
Direct PFC Responses in Irradiated Mice Injected with 5 X  10 6 Unfiltered Spleen Cells (No col), 
5  X  10 6 Spleen Cells Passed over RSA-Sepharose Columns  (RSA-S), or 5  X  10 6 
Spleen Cells Passed over H-RSA -Sepharose  Columns (H-RSA -S) from 
Immunized Donors* 
Mean  No.  of direct  PFC/spleen  Ratio  of  direct  PFC/spleen 
RSA-S  H-RSA-S  H-RSA-S  Experiment 
No.  No  col  RSA-S  H-RSA-S 
No  col  RSA-S  No  col 
1  1060  4-  204  1310  4-  224  4830  4-  873  1.2  3.7  4.6 
2  3550  :k  910  4370  -4-  793  19,300  ±  2470  1.2  4.4  5.4 
3  2370  4-  820  4340  4-  610  6940  4-  1680  1.8  1.6  2.9 
4  1960  4-  836  1890  -4-  302  4320  ±  080  0.97  2.3  2.2 
5  1350  ±  302  1870  4-  844  3040  ±  690  1.4  1.6  2.3 
6  1720  -4-  494  N.T.  9460  =E  1440  --  --  3.5 
7  1830  4-  164  N.T.  7160  4-  586  --  --  3.9 
8  1220  4-  292  N.T.  4050  -4-  1110  --  --  3.3 
9  720  4-  158  N.T.  3490  4-  955  --  --  4.8 
10  1350  ±  276  N.T.  3850  -4-  1370  --  --  2.9 
No  col  =  not  passed  over  columns. 
4-  Indicates  standard  errors. 
N.T.,  not  tested. 
*  (BALB/c  X  C57BL/6)  F1 mice exposed  to  750 rads of  6°Co gamma  irradiation  were  injected with  5  X  10 t~ 
spleen cells  (mixed with 3  X  10s SRBC)  from syngeneic  donors immunized  7 days before with SRBC.  The  donor 
spleen cells were not passed over columns or were passed over either RSA-Sepharose  or H-RSA-Sepharose  columns 
before  transfer  into recipients.  Direct  PFC  assays were made  7 days after cell transfer. 
TABLE  II 
Direct PFC Responses  in Irradiated  Mice Injected with 5  or 10  X  10 6 Unfiltered  Spleen  Cells 
(No col),  or with 5 or 10  X  10 6 Spleen Cells Passed over H-RSA-Sepharose  Columns 
(H-RSA-S) from  Unimmunized  Donors* 
Mean  No.  of direct  PFC/spleen  Ratio  of direct  PFC/spleen 
Experiment  No.  H-RSA-S 
No  col  H-RSA-S 
No  col 
1  537  4-  411  1810  -4-  486  3.4 
2  I88  4-  71  755  ±  38  4.0 
3  109  4-  29  1380  ±  342  12.5 
4  270  4-  74  1190  4-  640  4.4 
3  1860  4-  122  5370  4-  2380  2.9 
6  711  :::1: 195  2620  4-  195  3.7 
±  Indicates  standard  errors. 
*  (BALB/c  X  C57BL/6)Ft  mice exposed  to 750 rads of  6°Co  gamma  irradiation  were  injected with  5  X  106 
(experiments  1  4)  or with 10 X  10 s  (experiments  5 and  6)  (mixed  with 3  X  l0  s  SRBC)  from  unimmunized  syn- 
geneic  donors. The  donor spleen cells were not passed  over columns  or were passed  over H-RSA-Sepharose  col- 
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respectively. The above results obtained for direct and indirect PFC  suggest 
that the histamine columns retained cells which act to suppress the antibody 
response. 
Since plaque-forming cells are retained by H-RSA-S columns (18),  the en- 
hanced responses observed as a function of cell fractionation could have been 
due to the removal of antibody-producing cells which might have regulated the 
level of responsiveness via antibody-feedback mechanisms  (5). In order to ex- 
clude this  possibility,  spleen cells from immunized  donors were passed  over 
H-RSA-S columns, and equal numbers of the cells not retained by the columns, 
as well as unfiltered cells, were injected into groups of irradiated recipients with 
3 X  l0  s SRBC. The mean numbers of direct PFC obtained are shown in Table 
II. An  enhancement of from 2.9-  to  12.5-fold was obtained in the number of 
direct PFC generated by the cells passed over H-RSA-S. These results verify 
those shown in Table I  and support the hypothesis that a cell type expressing 
histamine receptors on its surface has a regulatory effect on the PFC response 
to SRBC. 
DISCUSSION 
A few reports have appeared recently assigning to certain cells the capacity 
to decrease antibody responses (mentioned in reference 4). Although the sup- 
pressor function has been ascribed to a population of thymus-derived cells (4), 
such cells have not been previously associated with a receptor to a physiological 
substance. The results presented here demonstrate that removal of cells based 
on a  specific interaction of a physiologically active agent, histamine, with its 
natural receptor can lead to significantly enhanced antibody responses of both 
the IgM and IgG classes.  The fact that H-RSA-S fractionation of spleen cells 
from unimmunized  donors  also  generated  elevated PFC  responses indicated 
that cells possessing regulatory function exist in the splenic compartment before 
active immunization. Whether these cells are of thymic origin and similar to 
those described by Gershon et al. (4) has not yet been established. 
It is likely that the differences observed in the immune potential of the frac- 
tionated  and  control cells  are  the result  of cell separation by the H-RSA-S 
column, and are not due to pharmacological effects of histamine on the cells. 
The drug-Sepharose conjugate does not stimulate cyclic AMP, which would be 
expected were the pharmacological effects of histamine directly involved (20). 
We  have  previously observed  that  among  the  cells  possessing  histamine 
receptors are the direct and indirect PFC, which are specifically bound to the 
histamine-coated columns (18). On the other hand, the present report demon- 
strates the enhancement of immune response potential upon passing spleen cells 
over the histamine-coated columns.  Retention of PFC  by H-RSA-S columns 
cannot  account  for  the  enhanced  responses  via  removal  of  the  source  of 
antibody-feedback suppression,  since enhancement of the PFC  response was 
demonstrated  using  spleen  cells  from unimmunized  donors.  Furthermore,  a 
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columns, despite the fact that enhanced PFC responses are generated by spleen 
cell transfers in this strain after passage of splenic precursor cells over H-RSA-S 
columns (manuscript in preparation). Thus, enhancement of secondary immune 
response potential was obtained without the concomitant removal of antibody- 
forming cells. 
The results reported here open for investigation a number of questions con- 
cerning the nature of this regulatory phenomenon:  (a)  Can the cells bound to 
H-RSA-S  generate  an  antibody  response  independently  of  the  cells  passed 
through  the  column?  (b)  Can  a  distinction  be  made  between  a  direct  cell- 
mediated modification of the immune response and a humoral substance which 
these cells may release? (c) Are the cells with regulatory function qualitatively 
or quantitatively  altered by immunization?  (d)  Will addition  of the regulator 
cells back to the passed cells or to a  normal suspension of  immunocompetent 
cells suppress responsiveness? (e) Does the regulatory cell population constitute 
a  heretofore functionally unidentified  class  of  cells,  or  is  it  a  subpopulation 
found in the thymus- or marrow-derived cell compartments? Studies concerned 
with identification of the source of these cells, and characterization of the cellutar 
and/or  molecular events involved in  this  regulatory process  are  in  progress. 
SUMMARY 
Spleen cells from immunized and unimmunized mice were either passed over 
histamine-rabbit serum albumin-Sepharose columns or rabbit serum albumin- 
Sepharose  control  columns.  The immune response potential  of 5  X  106  cells 
excluded from the  two columns were compared with each other,  and with an 
equal number of unfiltered cells by injection of the cell suspensions mixed with 
sheep erythrocytes into irradiated, syngeneic recipients. The direct and indirect 
anti-sheep  erythrocyte  plaque-forming  cell  responses  generated  by  the  cells 
passed  over  the  histamine-bead  column  were  significantly  greater  than  the 
responses resulting from the inocula of unfiltered cells or cells passed over con- 
trol columns. These results indicate the existence of a cell population expressing 
surface receptors for histamine, which functions to regulate antibody responses. 
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